Abstract We recently ldentlfied a subgroup of rabbits (called nonresponders) that were deficient m vascular thromboxane A2 receptors Thromboxane A*-mechated platelet aggregation was not different between responders and nonresponders In the present study, we utthzed these nonresponders as a model to study the relative contribution of the platelet and vascular thromboxane Az receptors to the observed hemodynanuc responses associated with aracludomc acid-induced sudden death. Mean arterial pressure was slightly but not significantly lower m the nonresponders compared with the responders. However, nonresponders were protected from aracludomc acid-induced sudden death While 100% of the responders died at the 2 0 mg dose of aracludomc acid, only 27% of nonresponders died at this same dose. Admmlstration of the thromboxane AZ mimetic U46619 (5 pg/kg IV) decreased blood pressure by 4126 mm Hg m responders but had no effect m the nonresponders The affinity and density of thromboxane AZ receptors m cultured aortlc vascular smooth muscle cells obtained from both responders and nonresponders were assessed using rachohgand bmdmg The Kd values were not different (4 421 0 versus 2 420.6 nmol/L, responder versus nonresponder) However, there was a significant decrease m the density of receptors from vascular smooth muscle cells of nonresponders (B,,,=397+59 versus 1.57259 fmol/106 cells, responder versus nonresponder, R.01). U46619 produced a concentrabon-dependent increase m ['HI-thymldine mcorporatlon mto responder vascular smooth muscle cells but had no effect m the nonresponder cells Using an anti-thromboxane AZ receptor antibody, we compared the amount of receptor expressed m aortic tissue obtained from responders and nonresponders Consistent with the results observed wrth [3H]-thymuhne uptake and radlohgand bmdmg assays, the expression of thromboxane A2 receptor protein was decreased in nonresponder compared with responder vascular tissue Platelet thromboxane AZ receptor expression was not &fferent These studies demonstrate that the vascular smooth muscle cells of nonresponder rabbits are deficient m the thromboxane Az receptor Furthermore, the reduction m aracludomc acid--induced sudden death m nomesponders mchcates that the vascular smooth muscle thromboxane AZ receptor mediates this effect (Hypertension. 1997;29[part21: 303.309.) Key Words l thromboxane Al l vascular smooth muscle cells l aracludomc acid l mean arterial pressure l rachohgand bmdmg l U46619 l rnitogenesls A n increased synthesis of thromboxane (TX) A2 1s associated with a number of cardiovascular dlseases including pulmonary hypertension, unstable angina and myocardlal ischemla. 1 TXA2 and Its immediate precursor, PG Hz (PGHJ, induce platelet aggregatlon and vascular smooth muscle vasoconstrlctlon.2 TXAl is also mitogemc for vascular smooth muscle.3-5 TXA2 and PGHz share a common membrane-bound receptor, and these receptors are found m a vanety of tlssues, including platelets and vascular smooth muscle cells.6 Using methods of equlhbrmm hgand bmdmg, platelets and blood vessels reversibly bind TX agonists and antagonists and have saturable bmdmg sites that are specific for TX agonists and antagomsts.7-13 The receptor from the human platelet has been purified, and the receptors from the placenta and megakaryocyte have been cloned 14~5 A splice variant of this placental receptor has been described m endothehal cells 16 The vascular receptor has not been purified or cloned to date
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We recently reported that a subgroup of rabbits was deficient m vascular TXA2 receptors. 17 Pulmonary arteries obtained from these rabbits, termed nonresponders, failed to contract to TXAz agonists. However, the vas- Q 1997 American Heart Assoclatlon, Inc cular responses to other vasoconstrictor agents such as norepinephrme, KCl, and endothehn were not altered m the nonresponder rabbits. When we prepared membranes from vessels of responder and nonresponder rabbits, there was a significant decrease in TXAl receptor number m the nonresponders. These findings were not resttlcted to the pulmonary vasculature as the decrease in TXA;, receptors and lack of vasoactive effect of the TXAz mlmetics were also observed m the aorta, supportmg the results of Keith and Salama.'* In contrast to the absence of vasoconstnctor effects of TXAz agonists in vascular tissue from nonresponder rabbits compared with responder rabbits, we also reported that the platelet aggregatory response to TXAz agonists was similar between the two groups 17 Platelet receptor number was not dlfferent m responders and nonresponders. Thus, the nonresponder rabbits were deficient m vascular but not platelet TXAz receptors. The rank-order potency of activity and binding of TX agonists differs between platelets and blood vessels, suggesting that the platelet and vascular TXA2 receptors are not the same 1~12 A difference m the potency of TX antagonists was also reported between these tissues In contrast, other studies provided pharmacologlcal evidence that the platelet and vascular receptors are similar.gJg~*O One hmltatlon to studying the role of TXA2 m cardlovascular disease has been the inability to differentiate the contrlbutlons of the platelet and the vascular smooth muscle to the observed hemodynamlc responses. For exam-Selected Abbreviations and Acronyms HR = heart rate I-BOP = [IS-(lol,2P(5Z),3cr(lE,3R*),4cu)]-7-[3-(3-hydroxy-4-(4'-todophenoxy)-1-butenyl)-7-oxabtcyclo [2 2 llheptan-2-yl]-5-heptenolc acid MAP = mean arterial pressure PAGE = polyacrylamtde gel electrophorests PG = prostaglandm PRP = platelet-rich plasma TTBS = Trrs-buffered salme (20 mmol/L TRIZMA hydrochloride, 500 mmol& NaCl, pH 7 5) wtth Tween-20 TX = thromboxane ple, Lefer and coworkers21*22 showed that arachrdomc acid (2.0 mg/kg IV) caused death within 5 minutes m rabbits. This arachldomc acid-induced sudden death has been observed m a number of other species 23,24 Pretreatment with an inhibitor of TXA2 synthase or with a TXA2 receptor antagonist protects the animals from arachldomc acid-induced sudden death,22 suggesting that the sudden death 1s due to an action of TXA2 at the platelet to cause intravascular platelet aggregation, at the vascular smooth muscle to cause vasoconstriction, or at the bronchtoles to cause bronchoconstrictron. Since there is no evidence that rabbit airway smooth muscle cells have TXA2 receptors,25 arachldonic acid-induced sudden death m rabbits 1s mediated through either the platelet or vascular smooth muscle receptor Because the TXA2 antagonists are not selective and cannot dlstmgmsh between vascular and platelet receptors, 11~~ the nonresponder rabbits provide an effective model to examine the role of the vascular versus the platelet receptor We hypothesized that because the nonresponder rabbits lacked vascular but not platelet TXA2 receptors, responses to arachtdomc acid would be reduced in the intact animal Specific expenments were designed to first characterize the vascular smooth muscle cell TXA2 receptor m responder and nonresponder rabbits and to then examme the contribution of thts vascular receptor to arachtdomc acid-induced sudden death in responder and nonresponder rabbits
Methods Materials
Arachldomc acid (sodium salt) was from Nu-Chek Prep, Inc U46619, I-BOP, and TXB? were from Cayman Chemical Co [3H]-TXB2 was from Amersham [3H]-Thymrdme was from DuPont NEN SQ 29548 was provided by S J Lucama of BnstolMeyers-Sqmbb (Princeton, NJ). All cell culture reagents were purchased from GIBCO Flasks used m cell culture were from Corning All other chemrcals were of reagent grade Vascular Reactivity Two-to three-month-old male New Zealand White rabbits (New Franken Rabbitry, New Franken, WIS) were anesthetized with sodmm pentobarbrtal (120 mg/kg IV), and the aorta was removed and placed nnmedtately m Krebs' bicarbonate buffer of the followmg composrtron (mmol/L) NaCl 118, KC1 4, CaCl* 3 2, NaHCO, 24, KH2P04 14, MgSO, 1 2, glucose 11, pH 7 4 The aorta was cleaned of adherent fat and connectrve tissue usmg care not to disturb the endothehal layer Rings of aorta (3 to 4 mm) were obtained and suspended m 15 mL organ baths contaming Krebs' bicarbonate buffer, which was warmed to 37°C and contmuously aerated with a 95% Oa/5% COz mixture Isometric tension was measured with force-displacement transducers and recorded with a Grass model 7D polygraph Resting tension was adJusted to 2 g and the vessels were allowed to equilibrate for 1 hour The KC1 concentratton of the baths was increased to 40 mmol/L until stable, reproducible contractrons were produced After the vessels reached peak contractron to 40 mmol/L KCl, tissue baths were rinsed and the vessels allowed to return to restmg tension Responses to the TXAl mrmettc U46619 (lo-' mom) were obtained Results were expressed as the percent contraction of the maximal response to 40 mmol/L of KC1 Animals m which the aorttc rmgs contracted to KC1 but not to U46619 were called nonresponders 17
Cell Culture
Vascular smooth muscle cells were Isolated and cultured from responder and nonresponder rabbit aortas using prevtously described methods 26 After collectron of endothehal cells,26 strips of denuded vessels were placed mto gelatin-coated flasks wtth Ml99 medmm contaming 10% fetal calf serum with L-glutamme (1%) and antrbrottcs (1% antrbrotrc/anttmycottc solution, 10 000 U pemcrllm, 10 mg streptomycm, and 25 ng amphoterrcm B [Sigma Chemical Co]) Smooth muscle cells migrated to the flasks wrthm 3 to 5 days Once growth was estabhshed on the coated Aasks, then the vessels were removed and the cells resuspended m Ml99 medium contaming 20% fetal calf serum Purity of smooth muscle cells was confirmed by positive stammg for smooth muscle cell cr-actm For radtohgand bmdmg and [3H]-thymrdme uptake assays, cells m second or third passages were used
Radioligand Binding
For measurement of TXAl receptors, confluent aorttc vascular smooth muscle cells obtained from responder and nonresponder rabbits were detached with 0 04% trypsm m PBS The equthbrmm bmdmg studies were performed by mcubatmg ahquots of cells (2.5X105) for 30 minutes at 37°C with 2X104 cpm of the TXA, agonist '251-BOP (2000 Ci/mmol)i3 and varymg concentrations of '*'I-BOP m a final volume of 0 2 mL The reactton was terminated by the addition of 4 mL of me-cold 50 mmol/L Tns HCl (pH 7 4) followed by the filtratron of the sample through Whatman GF/C glass fiber filters The filters were then washed with three addrttonal 4-mL volumes of buffer, and bound radroactivity was counted m a gamma counter (Packard Instrument Co) Nonspectfic bmdmg was determined m the presence of the TXA2 receptor antagonist SQ 29548 (10e5 mol/L)
Measurement of r3H]-Thymidine Incorporation
To measure [3H]-thymtdme mcorporatron,3 vascular smooth muscle cells from responder and nonresponder rabbit aortas were grown to 60% confluence m 24-well plates The cells were exposed to DMEM containing antrbtotrcs (1% antrbrottc/anttmycotrc solutton) and 0 5% fetal bovine serum to arrest cell growth After 48 hours, new DMEM was added containing 0 5% fetal bovine serum, and the cells were stimulated with mcreasmg concentrations of U46619 for 24 hours In some expenments, the TXAl receptor antagonist SQ 29548 (10e5 mol/L) was included m the mcubatron [3H]-Thymtdme (1 @/well) was added during the final 4 hours The medium was removed, and cells were washed with me-cold PBS, followed by 0 3 mL of me-cold perchlortc acid (0 3 mom) and PBS. In order to solubthze the cells, 0 5 mL of 0 1% SDS/O 1N NaOH was added to each well Radroacttvrty m the solubrhzed monolayer was determined by hqmd scintillation spectrometry PAGE and Western Blotting Rabbit aorta was obtained from responder and nonresponder rabbits as described above Whole blood from responder and nonresponder rabbits was collected m 3 2% sodium citrate (pH 7 4, 9.1) PRP was prepared by centrifuging the blood at 150g for 10 minutes The PRP was centrifuged at 1OOOg for 20 minutes to obtain the platelets Platelet and aorttc lysates were prepared by homogemzmg samples m a buffer containing 20 mmol/L HEPES, 255 mmol/L sucrose, 1 mmol/L EDTA, and 100 pmol/L phenylmethylsulfonylfluonde, pH 7.4 The protein lysates (10 @g/lane) were resolved by SDS-PAGE by the method of Laemmh27 and Cohgan et al28 using a 4% acrylamlde stackmg gel and 10% acrylarmde resolvmg gel 29 The protems were electrophoretlcally transferred to mtrocellulose, and the mtrocellulose membrane was blocked for 4 hours at 4°C with 2% nonfat dry rmlk in Tns-buffered saline (20 mmol/L TRIZMA hydrochloride, 500 mmol/L NaCl, pH 7 5) with Tween-20 (TTBS) before mcubation with a polyclonal TX receptor antibody (kindly provided by Dr Guy Le Breton, University of Illinois, Chicago). Incubation with the pnmary antibody was at a dilution of 1 1000 for 1 hour at 4°C Followmg washmg, the blot was Incubated for 30 minutes with the secondary antibody (horseradish peroxldaseConJugated goat anti-rabbit IgG antibody ) at a dilution of 1 3000 After again washing with TTBS, the blot was incubated for 1 mmute with DuPont Renaissance chermlummescent reagents The membrane was subsequently exposed to Kodak Blomax MR scientific imaging film to visualize protein separation Prestamed protem markers (Sigma) were used for molecular mass determmatlon
Hemodynamic Measurements
The central ear artery from rabbits was cannulated with an Exe1 SafeLet catheter (24 gauge by 3/4") under local anesthesia using hdocame/pnlocame cream (Astra Pharmaceutical Products, Inc) MAP was measured m conscious rabbits using a Narco pressure transducer and a Grass model 7D polygraph HR was obtained from the arterial blood pressure tracing Rabbits were monitored m a quiet room for =30 minutes before drug adrmmstratlon Followmg the measurement of MAP and HR m the conscious rabbits, the animals were anesthetized with sodium pentobarbltal(30 mg/kg IV) Sodium arachldomc acid was diluted m 1 mmol/L Na2C0, Just prior to use and injected into the ear vein at varymg concentrations (vehicle, 0 5, 1 0, and 2 0 mg/kg) over a 15 to 20-second period MAP was contmually monitored The vehicle had no effect on MAP or HR m either group of rabbits. In a separate experiment, atumals were admmlstered U46619 (5 /.&kg IV; m saline) and hemodynamlc responses momtored Followmg both the arachldomc acid and U46619 experiments, aortas were removed and suspended m tissue baths, and contractile responses to LJ46619 were determined as described above
Synthesis of TXAz
Blood was collected from responder and nonresponder rabbits m tubes containing heparm (1000 U/mL) and mdomethacm (10 pmol/L) at 4°C The plasma was obtamed following centnfugation at 15OOg for 10 minutes at 4°C. Plasma samples were extracted as previously described. 30 Bnefly, 1000 cpm of 3H-TXB2 was added to each plasma sample to be used for calculation of extraction recoveries The sample was acidified to pH <2.0 and extracted over octadecylsilyl columns The column was washed sequentially with 15% ethanol, water, and petroleum ether The TXBz was eluted with ethyl acetate, evaporated to dryness under a stream of nitrogen, and reconstituted m toluene/ethyl acetate/ methanol/glacial acetic acid (60.40 5 0 01) The sample was then purified over a slhclc acid extraction column The column was rmsed with toluene/ethyl acetate/methanol (60*40*3) TXBl was eluted with toluene/ethyl acetate/methanol/water (60 40.4 5 0 l), evaporated under a stream of nitrogen, and dissolved m 0 1 mol/L sochum phosphate buffer contammg 0 1% polyvmylpyrrolldone. TXBz was measured m the extracted samples by specific racholmmunoassay 30 The antlbodles for TXBz were produced m rabbits m our laboratory The sensltlvlty of the assay 1s less than 1 pg and the cross-reactivity of the TXBz antisera with known arachldomc acid metabohtes 1s less than 0.1%
Statistical Analysis
Data are expressed as the mean?SEM for observatrons m vessels obtained from different rabbits When multiple comparisons were made, statistical evaluation was performed usmg a one-way ANOVA followed by the Sidak multiple-comparison test when signrficant differences were present A Student's r test was used to analyze the radlohgand bmdmg, radmimmunoassay, and hemodynamlc data A value of P<.O5 was consldered statIstitally significant [ '*'I]BOP saturation data and Scatchard plots were determmed using a computer-assisted (PRISM) nonlinear regression analysis
Results

Vascular Reactivity Responses in Responder and Nonresponder Rabbits
Isolated aortlc rings were obtained from rabbits and tested for U46619mduced contractions In one group of rabbits, U46619 produced a concentration-dependent contraction (Fig 1) This group was referred to as responders. Aortlc rmgs from a second group of rabbits exhibited no contractile activity to U46619 and were called nonresponders. A total of 121 rabbits were used for the vascular reactivity, hemodynamtc, radtollgand binding, and cell culture studies Of that number, 35 (28.9%) were ldentlfied as nonresponders.
The maximal contraction to KC1 (40 mmol/L) was also compared m aortic rings from responder and nonresponder rabbits. No significant dtfferences m the ability of vessels from responders and nonresponders to contract to KC1 was observed (2 3+0.2 versus 2.520 2 g; responder versus nonresponder, NS).
Radioligand Binding in Cultured Vascular Smooth Muscle Cells Isolated From Responder and Nonresponder Aortas
The affinity and density of TXAl receptors in cultured aortlc vascular smooth muscle cells obtamed from both responder and nonresponder rabbits were assessed using "?-BOP Vascular smooth muscle cells from responder rabbits exhlbtted specific and saturable binding. In those nonresponder smooth muscle cell preparations where there was measurable binding, it was saturable. A representative analysis of the equilibrium binding studies including saturation curves (top) and the Scatchard analysts (bottom) 1s shown in Ag 2. The plasma concentrations of TXBZ were measured m samples obtained from responder and nonresponder rabbits TXB2 production was not different between the two groups of rabbits (183237 versus 240?76 pg/mL, responder versus nonresponder, respectively, n= 11, NS)
Expression of TXAz Receptor in Tissue From Responder and Nonresponder Rabbits
Utlhzmg a specific polyclonal anti-TXAz receptor antlbody, Western blot analysis showed the presence of lmmunoreactlve bands m lysates prepared from responder and nonresponder aortas and platelets (Fig 4) 
Hemodynamic Responses in Responder and Nonresponder Rabbits
MAP and HR measurements obtained from both conscious and anesthetized responder and nonresponder rabbits are summarized in Table 2 . Although MAP was slightly lower in the nonresponder rabbits than in the responder rabbits, the differences were not significant. When the 0.5 mg/kg dose of arachidonic acid was administered to responder rabbits, blood pressure decreased and 28% of the rabbits died (Fig 5) . In contrast, this same dose of arachidonic acid had no effect on the survival of the nonresponder rabbits. The 1 .O mg/kg dose of arachidonic acid elicited sudden death in 64% of the responder rabbits but only in 13% of the nonresponder rabbits. All responder rabbits (100%) administered the 2.0 mg/kg dose of arachidonic acid died whereas only 27% of the nonresponder rabbits died at this dose.
Because studies showed that the systemic administration of the TXA2 mimetic U46619 induced a fall in blood pressure and cardiac output in rabbits,32.33 we examined the effect of U46619 in responder and nonresponder rabbits. Twelve rabbits received U46619 (5 /*g/kg IV). Blood pressure decreased in seven of the animals (decrease in MAP, 41?6 mm Hg), and in three of the seven rabbits, pressure did not recover, and the animals died (Fig 6, A  and B) . HR was not altered by U46619 in the surviving rabbits (24526 versus 24327.2 bpm; pre-U46619 versus post-U46619; n=4; data not shown). Aortic rings obtained from these seven rabbits contracted to U46619 (maximal contraction, 128.9?7.1%, Fig 6C) , indicating that these rabbits were responders. In the additional five rabbits receiving U46619, there was no change in blood pressure (increase in MAP, 4.523.9 mm Hg) and none of these rabbits died (Fig 6A and 6B) . Again, HR was unaltered (257212 versus 250215 bpm, pre-U46619 versus post-U46619; n=5; data not shown). The contractile response to U46619 in isolated aortic rings obtained from these five rabbits was absent, indicating that these rabbits were nonresponders ( Fig 6C) .
Discussion
TXA2 is the predominant metabolite of arachidonic acid in platelets and is a potent inducer of platelet aggregation and constriction of vascular smooth muscle.2 Alterations in synthesis or activity of TXA? have been implicated as an important pathophysiological mediator of a number of cardiovascular diseases. 1 Although the specific receptor for TXA2 has been characterized both pharmacologically and molecularly, less is known about the physiological regulation of the receptor. We have recently found that a subgroup of New Zealand White rabbits did not contract to TXA2 agonists. 17 This subgroup of rabbits were referred to as nonresponder rabbits. Using a combination of physiological and pharmacological studies along with ligand binding, these animals were found to be deficient in the vascular but not the platelet TXA2 receptor. 17 In the present study, we have utilized these nonresponder rabbits as a model to assess the relative contribution of the platelet and vascular TXA2 receptors to the observed hemodynamic responses associated with arachidonic acid-induced sudden death. A number of m vitro experiments were performed to confirm that the vascular smooth muscle cell 1s the source of the TXA2 receptor m the responder rabbits Dorng had previously characterized the TXAZ receptor m cultured aorttc vascular smooth muscle cells obtained from rabbtts However, we examined ['251]-BOP bmdmg m vascular smooth muscle cells cultured from responder and nonresponder rabbit aortas that were first identified by the ability of aorttc segments to contract to the TXA2 agonist U46619 In this way, we could compare the responses m responder and nonresponder vascular smooth muscle cells While our results Indicated that the affinity of I-BOP for the receptor was not different between responder and nonresponders, there was a stgmficant decrease m receptor number m the nonresponder vascular smooth muscle cells Since the decrease m receptor number occurred m both acute vascular preparations17 and m cultured cells, these data would also suggest that the deficiency m receptors 1s related to a defect m the cell and is not related to a factor occurrmg m the intact animal No differences m ctrculatmg plasma TXAZ concentration were measured between responder and nonresponders Because a deficiency m receptor density occurred between cells from responder and nonresponder animals, tt was important to determine tf a functional difference existed between the cells Several recent studies have reported the ability of TXAz mimettcs to stimulate vascular smooth muscle cell growth via a TXAl receptor-mediated process 3-534 Cultured vascular smooth muscle cells obtamed from responder and nonresponder aortas were mcubated with varying concentrations of U46619 followed by a 4-hour labeling with The next series of experiments was performed to determme tf the receptor protein was present m the vascular tissue of nonresponder rabbits Using a polyclonal anttbody raised against native TXAl receptor protem,31 we compared the expression of the vascular receptor m aortic tissue obtained from responder and nonresponder rabbits Previous studies showed that the antibody recognized the vascular receptor m rabbits 31 Consistent with the results observed with [ 3H]-thymidme uptake and radtohgand bmdmg assays, the expression of TXA2 receptor protein was decreased m nonresponder compared with responder vascular tissue There was no change m this receptor m platelets from responder and nonresponders Fmally, an important observation from this study was the protectton of nonresponder rabbits from arachtdomc acid-induced sudden death. Prevtous studies indicated that TXA? mediates arachidomc acid-induced sudden death Sudden death could be blocked by TXA2 antagonists 21322 The antagonists are not selective and cannot distinguish between vascular and platelet receptors 11,12 These rabbits provide an effective model to examme the role of the vascular versus the platelet receptor While 100% of the responder rabbits died at the 2 0 mg dose of arachidomc acid, only 27% of nonresponder rabbits died at this same dose The survival rate for nonresponder rabbits was 73% The mechanism for the protection m the nonresponder rabbits must be related to the decrease in vascular TXAz receptors since our previous study showed that the platelet receptor was unaltered m these rabbits I7 In addition, others reported that rabbit airway smooth muscle does not contract to TXA* agonists,25 ehmmatmg bronchoconstricnon as a mechamsm for arachidomc actd-induced sudden death m rabbits While the admmlstration of U46619 to isolated vessels elicits vasoconstriction, the in vtvo intravenous admmtstration of U46619 to rabbits produces a decrease m MAP32J3 and a fall m cardiac output 32 Because circulatmg platelet number also decreased m these rabbits,32 the authors hypothesized that U46619 stimulated platelet ag-Pfister et al Smooth Muscle Thromboxane Receptors and Sudden Death 309 gregation, and the consequent platelet entrapment m the pulmonary vasculature contributed to the reduction m cardiac output and fall m MAP. Alternatively, U46619 could directly stimulate the vascular TXA2 receptors to cause intense pulmonary or coronary vasoconstriction with an ensuing reduction m cardiac output Our data obtained from the intravenous administration of U46619 to responder and nonresponder rabbits would support the second mechanism. Only the responder rabbits demonstrated a fall in MAP in response to U46619 In nonresponder rabbits that lack vascular TXAz receptors but not platelet TXAz receptors, U46619 did not lower MAP or affect survival of the animal.
In summary, the present study identifies the presence of functional TXAz receptors on vascular smooth muscle cells of responder rabbits, whereas a deficiency in receptor protein, number, and function occurs m nonresponder rabbit cells The additional finding that nonresponder rabbits do not die when administered arachidomc acid supports our ongmal hypothesis that the vascular smooth muscle cell TXAz receptor mediates arachidomc acid-induced sudden death.
